Table of Contents

Helen Groves

Dr. Helen E. Groves, MB, BCh, BAO, PhD is a Canadian infectious diseases specialist based in Toronto, Ontario.

Career and Affiliations

SickKids

Groves is employed by SickKids in the Division of Infectious Diseases.1) 2)

University of Toronto

Groves works in the Department of Paediatrics at the University of Toronto.3)

Ontario COVID-19 Science Advisory Table

Groves is an observer of the Drugs & Biologics Clinical Practice Guidelines Working Group of the Ontario COVID-19 Science Advisory Table.4)

Research

Remdesivir

Groves was an author on a study on remdesivir, funded by Gilead Sciences and the National Institutes of Health (NIH), paid to the institutions of her colleagues.5) It was funded by the Agency for Healthcare Research and Quality.

The study was also facilitated by the Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS) Collaborative, which is sponsored by BioFire Diagnostics (a BioMérieux company), Cepheid, Evivo, GlaxoSmithKline, Horizon Pharma, Magnolia Medical Technologies, Roche and VigiLanz.6)

Influenza

Groves published research on the impact of COVID-19 on influenza.7)

Relationship with pharmaceutical companies

Groves received honoraria from AbbVie.8)

1) , 8)
Groves, H. E., Papenburg, J., Mehta, K., Bettinger, J. A., Sadarangani, M., Halperin, S., & Morris, S. (2021). 1188. The Effect Of The COVID-19 Pandemic On Influenza-Related Hospitalization, Intensive Care Admission And Mortality In Canadian Children. Open Forum Infectious Diseases, 8(Supplement_1), S685–S686. https://doi.org/10.1093/ofid/ofab466.1380
2) , 3)
Bruno, V., Tjon, J., Lin, S., Groves, H., Kazmi, K., Zappitelli, M., & Harvey, E. (2021). Peritoneal dialysis-related peritonitis caused by Gordonia bronchialis: first pediatric report. Pediatric Nephrology, 37(1), 217–220. https://doi.org/10.1007/s00467-021-05313-3
4)
About Us. Ontario COVID-19 Science Advisory Table. Retrieved April 28, 2022, from https://covid19-sciencetable.ca/about/
5)
Chiotos, K., Hayes, M., Kimberlin, D. W., Jones, S. B., James, S. H., Pinninti, S. G., Yarbrough, A., Abzug, M. J., MacBrayne, C. E., Soma, V. L., Dulek, D. E., Vora, S. B., Waghmare, A., Wolf, J., Olivero, R., Grapentine, S., Wattier, R. L., Bio, L., Cross, S. J., & Dillman, N. O. (2020). Multicenter interim guidance on use of antivirals for children with COVID-19/SARS-CoV-2. Journal of the Pediatric Infectious Diseases Society. https://doi.org/10.1093/jpids/piaa115
6)
Conference Sponsors. SHARPS. Retrieved May 9, 2022, from https://web.archive.org/web/20220509075141/http://pediatrics.wustl.edu/sharps/Annual-Conference/Sponsors
7)
Groves, H. E., Piché-Renaud, P.-P., Peci, A., Farrar, D. S., Buckrell, S., Bancej, C., Sevenhuysen, C., Campigotto, A., Gubbay, J. B., & Morris, S. K. (2021). The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada: A population-based study. The Lancet Regional Health - Americas, 1, 100015. https://doi.org/10.1016/j.lana.2021.100015